MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Relationship between low back pain-related disability and motor performance in people with Parkinson disease

    R. Duncan, K. Rawson, T. Baker, J. Cavanaugh, C. Colon-Semenza, T. Deangelis, D. Fulford, M. Lavalley, T. Nordahl, M. Saint-Hillaire, C. Thomas, J. Zajac, T. Ellis, G. Earhart (Saint Louis, USA)

    Objective: To determine the relationship between low back pain (LBP)-related disability and physical performance in people with Parkinson disease (PD). Background: Low back pain is…
  • MDS Virtual Congress 2021

    Evaluating the Relationship between Apathy and Grit as it Relates to Participation in a Community Exercise Program in the Population with Parkinson’s Disease.

    E. Kiernan (Gainesville, USA)

    Objective: The primary aim of this study was to explore the relationship between apathy levels of the PD individual and apathy levels of their caregiver.…
  • MDS Virtual Congress 2021

    GASTROINTESTINAL SYMPTOMS ARE ASSOCIATED WITH LEFT PREDOMINANT DOPAMINE TRANSPORTER BINDING DEFICIT IN PARKINSON´S DISEASE

    K. Murtomäki, T. Mertsalmi, E. Jaakkola, E. Mäkinen, R. Levo, T. Nojonen, M. Eklund, S. Nuuttila, K. Lindholm, E. Pekkonen, J. Joutsa, T. Noponen, T. Ihalainen, V. Kaasinen, F. Scheperjans (Helsinki, Finland)

    Objective: To assess correlations between functional gastrointestinal (GI) symptoms and nigrostriatal dopamine transporter imaging asymmetry in Parkinson´s disease (PD) patients. Based on a theory that…
  • MDS Virtual Congress 2021

    Mood is a Key Factor in Progression of Non-Motor Symptoms Burden in Parkinson´s disease.

    D. Santos García, C. Cores, T. de Deus, J. Paz González, C. Martínez, E. Suárez, S. Jesús, M. Aguilar, P. Pastor, L. Planellas, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, M. Catalán, V. Nogueira, V. Puente, J. García Moreno, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo, J. Martínez Castrillo, P. Sánchez Alonso, G. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Blázquez, M. Seijo, J. Ruíz Martínez, C. Valero, M. Kurtis, O. de Fábregues, J. González, C. Ordás, L. López Díaz, P. Mir, P. Martínez Martín, C. Coppadis (A Coruña, Spain)

    Objective: The aim of the present study was to identify predictors of non-motor symptoms burden non-progression (NMSB-NP) in PD patients from a Spanish cohort  [1,2].…
  • MDS Virtual Congress 2021

    Relationship between frequency and severity of REM sleep behavior disorder and clinical features in patients with Parkinson’s disease

    JY. Wang, Y. Shen, CF. Liu (Suzhou, China)

    Objective: We aimed to explore the relationship between  frequency and severity of REM sleep behavior disorder(RBD) and clinical characteristics in Parkinson's disease (PD) patients. Background:…
  • MDS Virtual Congress 2021

    Sphingosine-1-phosphate, motor severity and progression in Parkinson’s disease (MARK-PD)

    C. Choe, C. Englisch, L. Niemann, S. Lezius, M. von Lucadou, K. Marmann, R. Böger, S. Peine, G. Daum, C. Gerloff, E. Schwedhelm (Hamburg, Germany)

    Objective: We assessed the association of serum sphingosine-1-phosphate (S1P) levels with motor and cognitive symptoms in patients with Parkinson’s disease (PD). Background: Treatment with sphingosine-1-phosphate…
  • MDS Virtual Congress 2021

    Daily fluctuations of plasma ghrelin level in patients with different motor subtypes of Parkinson`s disease

    K. Tarianyk, A. Shkodina (Poltava, Ukraine)

    Objective: The objective of this study is to compare evening and morning plasma ghrelin level in patients with different motor subtypes of Parkinson`s disease (PD).…
  • MDS Virtual Congress 2021

    Parkinson’s disease patients with hallucinations exhibit dopaminergic degeneration and cortical thinning

    C. Wertz, K. Poston, N. Shaff, A. Hartman, A. Horner, A. Mayer, A. Vakhtin, A. Deligtisch, S. Pirio Richardson, S. Ryman (Albuquerque, USA)

    Objective: Examine whether Parkinson’s disease patients (PD) who experience hallucinations (PD+hall) exhibit a greater decline in striatal dopamine and corresponding posterior cortical decline relative to…
  • MDS Virtual Congress 2021

    MOVEMENT DISORDERS IN CHILDREN WITH ATP1A3 GENE MUTATIONS. A SERIES OF CHILEAN PATIENTS

    M. Troncoso, D. Munoz, V. Naranjo, M. Matamala, J. Tello, S. Witting, A. Barrios, M. Hidalgo, I. Ruiz (Santiago, Chile)

    Objective: Describe the most frequent abnormal movements, their association with other symptoms, and the response to treatment in 4 children with ATP1A3 gene mutations. Background:…
  • MDS Virtual Congress 2021

    A novel tele-rehabilitation program aimed at reducing fall risk in Parkinson’s Disease patients

    M. Afshari, A. Hernandez, C. Goetz, J. Joyce (Chicago, USA)

    Objective: Our primary objective is to test the feasibility and preliminary efficacy of a novel falls-prevention program that uses videoconferencing technology to provide Parkinson’s Disease…
  • « Previous Page
  • 1
  • …
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley